Mike Werner, DMD, MS
Friday, April 3, 2009
9 am - 12 pm
3 CE credits
Recommended for: Dental Team
Bisphosphonates and Osteonecrosis
The role of the class of drugs known as the Bisphosphonates (Fosamax and Boniva are two examples) in the treatment of osteoporosis and osteopenia will be studied. These two diseases themselves will be defined and reviewed. The public health impact of these diseases will be explored, and the impact of the treatment of these diseases on the practice of dentistry will be reviewed.
- Participants will gain an understanding of the diseases known as osteoporosis and osteopenia.
- Participants will understand the public health impact of these diseases.
- Participants will understand the role of bisphosphonates in treating these diseases.
- Participants will be able to define bisphosphonate related osteonecrosis.
- Participants will understand the staging and treatment of bisphosphonate related osteonecrosis.
Mike Werner, DMD, MS was born in New York City and raised in Woodcliff Lake, New Jersey. He is a graduate of the University of North Carolina at Chapel Hill with a BS in Zoology. He received his DMD from the College of Medicine and Dentistry of New Jersey in 1979. Dr Werner completed a 27 year career in the US Army Dental Corps in 2006 and is now in practice at South Sound Oral Surgery which has offices in Olympia and Centralia Washington. Dr. Werner was a general dentist for ten years and became a fellow in the Academy of General Dentistry before entering an oral surgery residency in Honolulu, Hawaii. He served as the Residency Program Director and Chief of the Oral and Maxillofacial Surgery Department at Madigan Army Medical Center Dr. Werner has published articles in the Journal of Oral and Maxillofacial Surgery, the Journal of the US Army Medical Department, and Clinical Nuclear Medicine. He has presented lectures and research abstracts both nationally and internationally.